Clinical Trial Update: MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for MEDI9447 (oleclumab) in combination with pancreatic chemotherapy in metastatic pancreatic adenocarcinoma; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of the Pancreas
• Pancreatic Adenocarcinoma

Drugs mentioned

• MEDI9447 (oleclumab) (oleclumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Carcinoma, Metastatic Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-10-03